Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Spectrum of Dystonia in Spinocerebellar Ataxia

View through CrossRef
Background: Spinocerebellar ataxias (SCAs) are a diverse group of inherited disorders characterized by progressive cerebellar dysfunction. Beyond the classic ataxic features, dystonia is an important manifestation across both common and uncommon SCA subtypes. The complete clinical spectrum, pathophysiology, and treatment of dystonia in SCA remain incompletely understood. Objectives: This review aims to summarize the current literature on dystonia in SCAs, outlining its prevalence, clinical presentations, underlying mechanisms, and therapeutic strategies. Methods: The authors conducted a systematic literature review in PubMed (up to October 2025) with various search terms related to dystonia and spinocerebellar ataxia, including specific SCA types. Full text articles were included in the review based on clinical relevance. Results: Dystonia has been observed in the common SCAs such as SCA1, 2, and 3, as well as several of the rarer SCA types. While focal dystonias such as cervical dystonia and task-specific dystonia (writer’s cramp) are frequent manifestations, generalized dystonias are also documented. Dystonia may follow the ataxia, or can be the presenting symptom itself. Dystonia in SCA results from dysfunction in the interconnected brain networks primarily involving the cerebellum, basal ganglia, thalamus, and sensorimotor cortex. An altered dopaminergic signalling may be present as well. Treatment responses to levodopa, anticholinergics, botulinum toxin, and deep brain stimulation vary widely, underscoring the need for individualized therapeutic approaches. Conclusions: Recognizing dystonia as a part of the SCA spectrum is important for timely diagnosis and management. Further studies are required to elucidate the mechanisms and explore the targeted interventions.
Title: Spectrum of Dystonia in Spinocerebellar Ataxia
Description:
Background: Spinocerebellar ataxias (SCAs) are a diverse group of inherited disorders characterized by progressive cerebellar dysfunction.
Beyond the classic ataxic features, dystonia is an important manifestation across both common and uncommon SCA subtypes.
The complete clinical spectrum, pathophysiology, and treatment of dystonia in SCA remain incompletely understood.
Objectives: This review aims to summarize the current literature on dystonia in SCAs, outlining its prevalence, clinical presentations, underlying mechanisms, and therapeutic strategies.
Methods: The authors conducted a systematic literature review in PubMed (up to October 2025) with various search terms related to dystonia and spinocerebellar ataxia, including specific SCA types.
Full text articles were included in the review based on clinical relevance.
Results: Dystonia has been observed in the common SCAs such as SCA1, 2, and 3, as well as several of the rarer SCA types.
While focal dystonias such as cervical dystonia and task-specific dystonia (writer’s cramp) are frequent manifestations, generalized dystonias are also documented.
Dystonia may follow the ataxia, or can be the presenting symptom itself.
Dystonia in SCA results from dysfunction in the interconnected brain networks primarily involving the cerebellum, basal ganglia, thalamus, and sensorimotor cortex.
An altered dopaminergic signalling may be present as well.
Treatment responses to levodopa, anticholinergics, botulinum toxin, and deep brain stimulation vary widely, underscoring the need for individualized therapeutic approaches.
Conclusions: Recognizing dystonia as a part of the SCA spectrum is important for timely diagnosis and management.
Further studies are required to elucidate the mechanisms and explore the targeted interventions.

Related Results

Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study
Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study
Although there are several reports of the significant efficacy of zolpidem for treating dystonia, zolpidem is still considered an anecdotal treatment. Here, we evaluated the effica...
Decoding Dystonia in Autoimmune Disorders: A Scoping Review
Decoding Dystonia in Autoimmune Disorders: A Scoping Review
Background: Dystonia is a common hyperkinetic movement disorder observed in various genetic, infective, drug-induced, and autoimmune disorders. Autoimmune disorders can present wit...
Rare Variant Burden in Known Dystonia Genes in Population Controls and Sporadic Dystonia Patients
Rare Variant Burden in Known Dystonia Genes in Population Controls and Sporadic Dystonia Patients
Abstract Background Rare mutations in genes associated with Mendelian forms of disease are a potential mechanism for sporadic d...
Spinocerebellar ataxia type 21 exists in the Chinese Han population
Spinocerebellar ataxia type 21 exists in the Chinese Han population
AbstractRecently, mutations in transmembrane protein 240 (TMEM240) were identified as the cause of spinocerebellar ataxia type 21 (SCA21) in several French families. Clinically, SC...
Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy
Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy
Abstract Objective To determine how physicians approach pharmacologic dystonia treatment in people with CP and assess physician...
Genetics of the Autosomal Dominant Spinocerebellar Ataxias
Genetics of the Autosomal Dominant Spinocerebellar Ataxias
AbstractThe spinocerebellar ataxias (SCAs) are a clinically, genetically and neuropathologically heterogeneous group of neurological disorders defined by variable degrees of cerebe...

Back to Top